Association Between Statin Discontinuation After Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Initiation and Subsequent Atherosclerotic Cardiovascular Disease Events

Peasah SK, Lee T, Do D, Huang Y, Inneh A, Patel U, Aiyer AN, Good CB. Association Between Statin Discontinuation After Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Initiation and Subsequent Atherosclerotic Cardiovascular Disease Events. J Manag Care Spec Pharm, 2025 April;31(4):377-385. https://doi.org/10.18553/jmcp.2025.31.4.377